Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
We'll both know shortly, won't we?!
Just like u know the thawing device costs $20.....................jokes
If we don't hear anything on these 2 questions, Everyone should be very, very concerned. If would mean we can't facilitate compassionate use requests or Expanded Access requests.
Given the blockbuster nature of the indication, $0 would be damming IMHO.
Hopefully we will hear about more patents.! Not.
Something to hide... Expect the worst.
Probably a misstatement to repair, imo
Here are 2 very reasonable and pertinent questions that should be answered for all stock-holders ending this quarter:
1.) How many PLX-PAD patients have been treated under the FDA's Expanded Access Program YTD.?
2.) How much revenue has been generated via this program? Private pay, Insurance?
You cannot convince anyone that there are NO wealthy PAD patients that would be knocking the door down at PSTI to try this 'miracle'...
Show us the money!
These are exactly the KEY reasons why R-18 does not present a reasonable
'in theatre' rapid response to a radiation catastrophe.
2 Major Logistical Hurdles not easily overcome. PSTI will have to give away the 'thawing devices' by the thousands to make this doable. MAJOR, MAJOR EXPENSE HURDLE.
eply | Keep | Last Read
Post New Msg
Previous | Next
FDApproved
Followed By
2
Posts
2,860
Boards Moderated
0
Alias Born
03/11/17
Pluristem Therapeuti (PSTI)
1.33 ? 0.0 (0.00%)
Volume: 91,023 @ 2:54:38 PM EDT ET
Advertise Here
Invest for the long haul at E*TRADE.
Bid
Ask
Day's Range
1.32
1.33
1.31 - 1.33
PSTI Detailed Quote
1D
1M
2M
3M
6M
1Y
2Y
3Y
5Y
Advertise Here
Invest for the long haul at E*TRADE.
Pluristem Initiates Two Pivotal Phase III Studies in Israel GlobeNewswire Inc. - 8/8/2018 7:00:00 AM
Pluristem Granted Key Patent in Japan for Treatment of GI Following Acute Radiation Exposure GlobeNewswire Inc. - 7/26/2018 7:00:00 AM
Pluristem Signs Collaboration Agreement With Thermo Fisher Scientific GlobeNewswire Inc. - 7/9/2018 7:00:00 AM
Pluristem and Fukushima University Report Positive Data: PLX-R18 Increases Survival Rates and Mitigates Severe Intestinal Dam... GlobeNewswire Inc. - 6/25/2018 7:00:00 AM
U.S. Department of Defense to Study Pluristem’s PLX-R18 for the Treatment of Mustard Gas Injuries GlobeNewswire Inc. - 6/19/2018 7:00:00 AM
Pluristem to Open Weekly Market Trading at TASE Following Positive Study Results GlobeNewswire Inc. - 6/14/2018 7:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 6/12/2018 4:00:44 PM
Pluristem Reports Positive Top-Line Results from Its Multinational Phase II Intermittent Claudication Study GlobeNewswire Inc. - 6/12/2018 6:00:00 AM
Pluristem to Announce Top-Line Results of Its Multinational Phase II Intermittent Claudication Study on June 12, 2018 GlobeNewswire Inc. - 6/4/2018 6:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/31/2018 4:06:46 PM
Pluristem Reports Third Quarter Fiscal 2018 Corporate and Financial Highlights GlobeNewswire Inc. - 5/10/2018 7:00:00 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 5/9/2018 4:15:41 PM
U.S. FDA Clears Pluristem’s IND to Treat Victims Exposed to Acute Radiation GlobeNewswire Inc. - 5/2/2018 9:15:07 AM
U.S. FDA Clears Pluristem’s Phase III Study in Treatment of Muscle Injury Following Hip Fracture Surgery GlobeNewswire Inc. - 4/25/2018 7:00:00 AM
Pluristem and Indiana University to Initiate Joint Project Evaluating PLX-R18 in Acute Radiation Syndrome, Targeting Bridging... GlobeNewswire Inc. - 4/23/2018 7:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 4/3/2018 4:33:38 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 4/3/2018 4:13:19 PM
Roger Jeffs, Former Co-CEO of United Therapeutics, Joins Pluristem's Strategic Advisory Board GlobeNewswire Inc. - 3/26/2018 7:00:00 AM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/19/2018 5:09:43 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 3/15/2018 5:16:57 PM
Pluristem’s PLX-R18 Improves Hematopoietic Transplantation as Reported in Scientific Journal Frontiers in Medicine GlobeNewswire Inc. - 2/27/2018 7:00:00 AM
Pluristem Issues Letter to Shareholders GlobeNewswire Inc. - 2/7/2018 7:44:38 AM
Securities Registration: Employee Benefit Plan (s-8) Edgar (US Regulatory) - 2/6/2018 4:22:26 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 2/6/2018 4:08:38 PM
Pluristem’s PLX Cells Significantly Inhibit Cancer Cell Growth in Newly Published Study GlobeNewswire Inc. - 1/12/2018 7:00:00 AM
AFDApproved
Tuesday, 09/04/18 09:33:20 AM
Re: None
0
Post # of 15273
All Students Of Pluristem Know... That Is Precisely The Reason Pluristem Invented Their Unique Thawing Device That Insures 99% Survival Rate After Thawing ! Do Some DD For Once !
http://www.pluristem.com/additional-technologies/
FDA clears expanded access programme for Pluristem’s PLX-PAD cell treatment
EPM magazine, January 10, 2018
https://www.epmmagazine.com/news/fda-clears-expanded-access-programme-for-pluristem’s-plx-pad/
and yet... we still see NO revenue.
Scientists find ‘cure’ for nuclear radiation exposure
Energy Voice, July 27, 2017
https://www.energyvoice.com/other-news/healthandsafety/145698/scientists-find-cure-nuclear-radiation-exposure/
Pluristem, Sosei Set Up in Japan to Commercialize Cell Therapy for CLI
GEN news, December 20, 2016
https://www.genengnews.com/gen-news-highlights/pluristem-sosei-set-up-in-japan-to-commercialize-cell-therapy-for-cli/81253583
Mark my words... Mr. Jeff's agrees, changes coming!
mobile.twitter.com/Pluristem/status/10325870638483
Embarrassing!
It is absolutely no wonder why nobody takes this company and its leadership seriously. We have a great day too Miracle like products and Leadership that keeps us anchored to the bottom. Take a look it up poster presentation can we not have a professional presents for our booth for poster presentations? Our poster looks like a wrinkled bed sheet that flew over in someone's briefcase from Israel. We also look like we're dressed and ready to go to the theme parks today jokes!
The day you have to lower your price to sell your value is the first-last day of your business!
Price Proudly.
Your Welcome,
PERIANALFISTULALLO !
Yes allo
your Felicia69 alias still works.
Accumulation station.... Oh, my.
At these 10k clips, we are sure to climb just short of 'average volume' by eod.
Fake News. !
FDApproved...
She is the LEAD NEWS correspondent for WGAC. THE Who Gives A Crap channel... Fake News !
Should be pretty easy to identify them... Uh, don't ya think?
Well, actually, you got in early April 2017, so you are $1.20-$1.44.
zzaatt
Thursday, 07/26/18 12:22:01 PM
Re: EichKing post# 14203
0
Post # of 14214
Quote:
"too early" investors were duped
By whom? Early investments in biotechs is risky. You know what they say: "caveat emptor". That's Bulgarian for don't jump into biotechs too early.
As for me, you have no idea what my average is, and I wouldn't loose any sleep over it, I don't (but thanks for offering your free services as my accountant).
FDApproved
Tuesday, 05/23/17 10:04:54 AM
Re: None
0
Post # of 14210
Controller Working Hard To Keep It Near $ 1.40 !
He Will Lose Control Soon !
"Any stock that has previously undergone a 200:1 reverse split should make you very very nervous. That's a lot of believers who got wiped out. Now there's a whole new crop of Pluristem believers who are either unaware of the previous generation, or simply think they're much smarter."
Facts are just as rich today.
Have A Nice Day! :)
IF the controller conspiracy theory holds, it rests squarely on Leadership to have it SEC investigated... "manage the stock price"
https://www.reuters.com/article/us-biotech-fraud-blech/onetime-king-of-biotech-runs-afoul-of-law-again-idUSBRE8481GR20120509
They (we) are paying for past transgressions.
https://www.fiercebiotech.com/regulatory/biotech-gambler-blech-loses-big-securities-scam
the price is the price. NO controller necessary.
Now who looks like pumpers on this board?!?!
Because alloon loves seeking alpha as a market powerhouse... Thought all would enjoy this...
Facts and data and math...
https://seekingalpha.com/article/2875876-pluristem-therapeutics-questionable-ethics-and-bucket-shop-coverage
Knuckleheads.
Math, along with facts and data are not your strong suits allo. You make NO sense. I think it's 9/10 psti partnerships fail.
The fact is...
and alloohoo, you know the story better than anyone...
IMO, psti's legendary scam of all scams, pump and dump, early on in the stem cell space, is the single reason nobody on the street trusts this company.
If psti is the holy grail as you profess, then $5-6B is a BARGAIN... Even more of a bargain at today's price...
In fact, an outsider buying psti now, and failing, is a better play than waiting and succeeding... Do some math and YOU, get a clue....
So instead of said controller buying out now at $1.28, they artificially deflate the price?? Really?! Great strategy.
If they can control the price with hundered share blocks, why not but it now?
Otherwise, think about it..., they are daily giving away equity... Why?
2 points...
1. The gut data and patent do not matter. As pharmacy tech, Spideyboy recently pointed out, "gi isn't that important.."
2. IF, their actually was this controller, our crack-accountant CEO, would have the SEC investigate, wouldn't he? Unless he was on the take... Like the previous scammer history of leadership. IMO
Which is it????
Spidey, any time you want to review, post per post, bring it. Case in point, Neupogen. You pick and choose your data, side effects, and blur it all somehow, into a meaningless assertion of comparative quality to R18 MONKEY DATA... (MONKEY DATA THAT IS NOT EVEN POWERED TO SHOW EFFICACY)
THUS... and therefore, you disqualify your self, thusly. Go back and look for your self, it's all there. Don't flatter yourself with the fantasy thought that your somehow schooled me on cytokine science so I sought retreat. Funny.
Hardly, in fact, Neupogen will be used WITH R18 in the pivitol trials... Because, for now, it is the gold standard. PS, Your "no human safety studies" comment on r18, was ludicrous. ALL human exposures with r 18 are a part of the 'human safety studies/data'
So Fukushima you - should thus be more diligent in your dissenting.
Approximately 800 women die from pregnancy or childbirth-related complications around the world every day.(1) Ninety-nine percent occur in developing countries. The higher number of maternal deaths in some areas of the world reflects inequities in access to health services and the gap between rich and poor.
https://www.preeclampsia.org/health-information/149-advocacy-awareness/332-preeclampsia-and-maternal-mortality-a-global-burden
Dr. Kleinhouse, Dr.srdoughjack, Mr. Yanay, Dr. Aberman, FDA, zzatt, Spidey, bueller - please help us understand...
Where did Pre Eclampsia go?!?!?!
[color=red][/color]
Not even on the radar (Slide 13)... FAILURE! - especially with what we got out of the trial... Women & Babies suffering needlessly because of GREED. IMHO.
See for yourself:
https://seekingalpha.com/article/3859416-pluristems-placental-cells-prove-superior-pre-eclampsia-leading-cause-maternal-fetal-death
Why You Should Worry About Dark Pools !
Are we talking about #2's again?
Here Is A Better Educational Video.
On another Note: This Dark Pool Video Below, IMO..
Boy, I wish we had a CEO that was also an Accountant who was in-charge of "Managing the share price" for shareholders, he would be all over this!!!!
Oh, that's right... Maybe not qualified to deal with that either??
I am....like Methuselah old....waiting for PSTI to "Giddy Up!"
Said the spider to the fly...
Going to need a Lazarus experience here for psti. Good thing they are located in Isreal! ?????? Closest translation in Hebrew to "Giddy Up!" (Loopy) fitting.
The New Government Grant From Last Thursday Without Money Attached Yet ? Must Be For The Mustard Gas Study ?
Oh, yeah...that's it alloon. Mustard Gas. Like you after a trip to the ballpark.
And Dr. Who, Spiderbite, looks the Gov't. is deathly scared of G-csf eh? Combining it with r18? Oh my, what's the point, we read all the scary SEs you listed, must be poison...
THINNK ABOUT IT. Like I said, get back to filling prescriptions...
Very nice px action today.
Have to agree, its as though the controller is losing his kungfoo grip on the SP. May have to increase blocks to 150 shares to hold his ground.
Waffles... Its whats for dinner. Blues Clues!
Spideyboy
Friday, 04/28/17 09:58:21 AM
Re: bluehorsesho post# 4694
0
Post # of 14014
I very much believe that PLX-R18 for ARS will not need human safety studies.
Looking deeper into the matter there is an extra key item that lead me to this conclusion.
This being that I noticed on the Pluristem Corporate presentation - January 2017, that I mentioned before, that after the two expected ARS timeline events of:
- Data readout dose selection studies ARS - H1/2017
- Contract with U.S. government for ARS – H2/2017
there is another expected milestone immediately after which I didn't fully appreciate before which is:
- Initiation of pivotal study ARS NHP - H2/2017
It's the 'NHP' bit that threw me off originally however now I know this to mean Non-Human Primate. Having looked into ARS research on NHP this mean that, based on the research I've just read regards NHP in ARS they will use Macaque Rhesus Monkeys, for the final Pivotal stage.
So going on my understanding that I do not think the US gov nor Pluristem would go this far and then at the end to do safety data in humans and have it all fall apart, would be due to the following.
We know the current imminent data is a dose selection study. This requires testing the product in various animal models deemed to react similarly to how the pathophysiology might work in humans, to arrive at a does that would make sense for a human. And these large animal models (dog for example) might be easier to get approval for testing with regards ethical issues. As we all know, generally speaking, mice are the easiest and monkeys are among the hardest to get approval for.
Then after the treatment has been shown to work positively in multiple large animal models and a dosage can be identified (the ethically easier part). Then we go for the pivotal trial by performing the final test in an 'NHP' model.
In the final stage, the 'NHP' model could serve as both safety and efficacy without human testing. This due to the fact that Macaque Rhesus monkeys (the most commonly used NHP in research and has been specifically used in ARS research) are 93% genetically the same as humans. And the physiology of these monkeys has been well documented, thus the pathophysiology would be relatively straightforwards to analyse, with comparison to humans.
I admit this theory is not as 'good' as doing the safety in humans, but this is the only way I can see this making sense. Otherwise indeed, we would need to wait for specific R18 human safety data. Or then again maybe Allo is right and we're somehow missing something and thinking too much.
All said though, with my above theory and that I still feel strongly on the premise that they (US gov & Pluristem) could not have gone this far just to have it fall flat in their faces when they could have done safety studies back in 2015 when the NIAID was initially going with Pluristem to the FDA, would, I feel, honestly be ridiculous.
Thoughts?